i-SENS, Inc. (KOSDAQ:099190)

South Korea flag South Korea · Delayed Price · Currency is KRW
16,010
+160 (1.01%)
May 30, 2025, 3:30 PM KST
-13.97%
Market Cap 441.65B
Revenue (ttm) 299.00B
Net Income (ttm) 1.07B
Shares Out 27.59M
EPS (ttm) 38.21
PE Ratio 413.01
Forward PE 116.44
Dividend 100.00 (0.63%)
Ex-Dividend Date Dec 27, 2024
Volume 52,838
Average Volume 65,786
Open 15,800
Previous Close 15,850
Day's Range 15,700 - 16,160
52-Week Range 12,970 - 22,850
Beta 0.83
RSI 43.49
Earnings Date May 15, 2025

About i-SENS

i-SENS, Inc. engages in the development, manufacture, and sale of chemical and biosensors in South Korea and internationally. The company offers blood glucose monitoring devices; diabetes care, acute care, and coagulation care devices; veterinary care devices; and accessory products. It also provides SmartLog, a diabetes management software for mobile and PC. The company was founded in 2000 and is headquartered in Seoul, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2000
Employees 845
Stock Exchange KOSDAQ
Ticker Symbol 099190
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.